PAVmed Inc. Series Z Warrant
PAVMZ
PAVMZ was delisted on the 30th of April, 2025.
3 hedge funds and large institutions have $1.1K invested in PAVmed Inc. Series Z Warrant in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.
28% more capital invested
Capital invested by funds: $858 → $1.1K (+$240)
0% more funds holding
Funds holding: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$240 |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$15 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $918 | +$15 | +484 | +1% |
|
|
2
UBS Group
Zurich,
Switzerland
| $178 | +$240 | +7,857 | +1,310% |
|
3
Bank of America
Charlotte,
North Carolina
| $2 | – | – | – |
|
PAVMZ Hedge Fund Activity: Q3 2024 in Review
3 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q3 2024, worth a combined $1.1K — up 28% from $858 a quarter earlier.
Fund positioning in PAVMZ was balanced in Q3 2024: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $240.
- 3 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $1.1K of PAVmed Inc. Series Z Warrant stock for Q3 2024, up 28% quarter-over-quarter.
- 0 funds opened new PAVmed Inc. Series Z Warrant positions in Q3 2024 and 0 closed out.
- The largest PAVmed Inc. Series Z Warrant buyer in Q3 2024 was UBS Group, an estimated $240 added.
Based on aggregated 13F filings for Q3 2024.